10-Q: Genworth Financial Reports Q2 Profit Decline Amidst Legacy Business Challenges, Strategic Investments Continue

Genworth Financial, Inc. reported a significant decrease in net income and adjusted operating income for the second quarter and first half of 2025, primarily driven by challenges in its legacy insurance segments, despite ongoing strategic investments and strong capital positions in its mortgage insurance business.

Summary

• Net income available to common stockholders for the three months ended June 30, 2025, was $51 million, a 33% decrease from $76 million in the same period of 2024.
• Adjusted operating income for the three months ended June 30, 2025, was $68 million, a 46% decrease from $125 million in the prior year quarter.
• For the six months ended June 30, 2025, net income available to common stockholders was $105 million, down 40% from $215 million in 2024.
• Adjusted operating income for the six months ended June 30, 2025, was $119 million, a 43% decrease from $210 million in the first half of 2024.
• The Enact segment's adjusted operating income decreased by 15% to $141 million in Q2 2025, primarily due to a lower reserve release and higher new delinquencies.
• The Long-Term Care Insurance segment's adjusted operating loss increased by 28% to $37 million in Q2 2025, mainly due to non-recurring net insurance recoveries in the prior year and a higher remeasurement loss.
• The Life and Annuities segment's adjusted operating loss increased to $7 million in Q2 2025, driven by block runoff, unfavorable mortality, and lower net spread income.
• Total assets increased by $465 million to $87,336 million as of June 30, 2025, compared to December 31, 2024, primarily due to increases in fixed maturity securities and limited partnerships.
• Total equity increased by $348 million to $9,779 million as of June 30, 2025, largely due to unrealized gains on investments from decreased interest rates, partially offset by changes in the discount rate for future policy benefits.
• Genworth Holdings had $248 million of unrestricted cash and cash equivalents as of June 30, 2025, a decrease from $294 million at year-end 2024.
• The company repurchased $75 million of its common stock during the first six months of 2025, part of a total of $630 million repurchased since May 2022.
• The U.K. High Court issued a liability judgment in favor of AXA against Santander, potentially entitling Genworth to recover approximately $750 million, contingent on appeals and full payment.

Sentiment

Score: 4

Explanation: The overall sentiment is moderately negative due to significant declines in net income and adjusted operating income across most segments. While there are positives like strong capital ratios, ongoing share repurchases, and a potential large litigation recovery, these are overshadowed by the core business's declining profitability, increased losses in legacy segments, and persistent litigation risks. The increase in CareScout Insurance capital needs due to funding delays also adds a slight negative nuance.

Positives

• Net investment gains (losses) improved significantly, moving from a $(61) million loss in Q2 2024 to a $(28) million loss in Q2 2025, and from a $(12) million loss in H1 2024 to a $(1) million loss in H1 2025.
• The Enact segment maintains a strong PMIERs sufficiency ratio of 165%, or $1,961 million above requirements, as of June 30, 2025.
• The Long-Term Care Insurance multi-year in-force rate action plan has achieved an estimated cumulative economic benefit of approximately $31.6 billion on a net present value basis since 2012 through Q2 2025.
• A third-party reinsurance recapture in the Long-Term Care Insurance business resulted in a $26 million pre-tax gain in Q2 2025.
• Enact Holdings authorized a new share repurchase program of up to $350 million on April 30, 2025, demonstrating commitment to shareholder returns.
• Genworth Holdings received $94 million in capital returns from Enact Holdings during Q2 2025, comprising share repurchases and quarterly dividends.
• The company repurchased $75 million of its common stock in the first half of 2025, contributing to a total of $630 million in repurchases since May 2022.
• CareScout Services expanded its network to nearly 650 home care providers nationwide, with most offering hourly rates below the median cost of care in their respective zip codes.
• CareScout Services launched 'Care Plans,' providing virtual care evaluations and tailored aging care strategies, expected to contribute to fee-based revenue growth.
• CareScout Care Assurance, an individual long-term care insurance product, has been approved by 29 jurisdictions, with plans for a product launch later this year.
• The consolidated risk-based capital ratio of U.S. domiciled life insurance subsidiaries remains robust at approximately 304% as of June 30, 2025.
• The U.K. High Court issued a liability judgment in favor of AXA against Santander, which could entitle Genworth to recover approximately $750 million, a significant potential cash inflow.

Negatives

• Net income available to common stockholders decreased by 33% in Q2 2025 and 40% in H1 2025 compared to the prior year periods.
• Adjusted operating income decreased by 46% in Q2 2025 and 43% in H1 2025 compared to the prior year periods.
• Basic and diluted earnings per share saw significant declines, with basic EPS falling from $0.17 to $0.12 in Q2 and from $0.49 to $0.25 in H1.
• The Enact segment's adjusted operating income decreased due to a lower reserve release and higher new delinquencies.
• The Long-Term Care Insurance segment's adjusted operating loss increased, primarily due to non-recurring net insurance recoveries in the prior year and a higher remeasurement loss from unfavorable actual variances and cash flow assumption updates.
• The Life and Annuities segment's adjusted operating loss increased, largely due to continued block runoff, unfavorable mortality experience, and lower net spread income.
• Corporate and Other's adjusted operating loss increased due to higher expenses related to CareScout growth initiatives and lower net investment income.
• Allowance for credit losses on commercial mortgage loans increased by $20 million in Q2 2025 and $17 million in H1 2025, resulting from updates to the analytical model.
• Allowance for credit losses on available-for-sale fixed maturity securities increased by $11 million in Q2 2025 and $15 million in H1 2025.
• Net investment losses related to derivatives increased by $28 million in Q2 2025 and $23 million in H1 2025, primarily due to foreign currency forward contracts.
• The delinquency rate in the Enact segment increased to 2.32% as of June 30, 2025, compared to 1.96% as of June 30, 2024.
• Genworth Holdings' unrestricted cash and cash equivalents decreased by $46 million from December 31, 2024, to June 30, 2025.
• The planned capital contribution to CareScout Insurance for the full year 2025 increased from $75 million to $85 million due to later than originally anticipated funding and lower expected investment income.
• The company faces multiple ongoing class action lawsuits and regulatory matters across its segments, including those related to cost of insurance charges, fraudulent transfers, ERISA fiduciary duties, data security breaches, and policy terminations.

Risks

• Inability to successfully launch new lines of business, including long-term care insurance and other products and services being pursued with CareScout.
• Failure to maintain the self-sustainability of legacy U.S. life insurance subsidiaries, potentially due to inability to achieve desired levels of in-force rate actions or delays in future premium rate increases.
• Inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections, and/or models, which could result in inadequate reserves or other adverse financial results.
• Impact on holding company liquidity caused by an inability to receive dividends or other returns of capital from Enact Holdings, and limited sources of capital and financing.
• Adverse changes to the structure or requirements of Fannie Mae, Freddie Mac, or the U.S. mortgage insurance market, or an increase in federal government mortgage insurance programs.
• Changes in economic, market, and political conditions, labor shortages, and fluctuating interest rates, which could lead to market-wide liquidity problems, losses, defaults, or credit rating downgrades.
• Deterioration in economic conditions, a recession, or a decline in home prices, potentially driven by various factors.
• An increase in the cost of care impacting the long-term care insurance business, particularly due to elevated inflation.
• Changes in international trade policy, including new or increased tariffs, retaliatory policies, or trade wars, which could lead to political and economic instability.
• Downgrades in financial strength and credit ratings, and potential adverse impacts to liquidity.
• Counterparty credit risks, including defaults by counterparties to reinsurance arrangements or derivative instruments.
• Litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties, which could result in significant legal liability or reputational harm.
• The inability to effectively manage information technology systems, cyber incidents, or other failures, disruptions, or security breaches, including those involving third-party vendors.
• The impact of medical advances, emerging new technology (including artificial intelligence), and related legislation.
• Quarterly adverse variances between actual and expected experience could persist, resulting in future remeasurement losses in the long-term care insurance business.
• The potential recovery in the AXA and Santander litigation is subject to a successful appeal, significant delays, or other adverse developments.
• The majority of Enact's mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.
• The company's long-term care insurance business is sensitive to movements in interest rates, which will likely result in continued volatility to reserve balances and equity.
• Renewal premiums on the in-force block of the legacy long-term care insurance business are expected to decline over time as the block runs off, partially offset by future approved rate actions.
• Mortality levels in life insurance products may deviate each period from historical trends, and reinsurance costs typically increase due to natural aging of yearly renewable term reinsured blocks.
• Declines in fixed annuity spreads and margins could continue as interest rates change.
• Equity market volatility and interest rate movements may continue to cause fluctuations in variable annuity products and regulatory capital requirements.

Future Outlook

The company plans to drive future growth through CareScout with innovative, consumer-focused aging care services and funding solutions, investing approximately $45 million to $50 million in CareScout Services for the full year 2025. It also plans to contribute $85 million of capital to its CareScout Insurance subsidiary in 2025 to meet regulatory capital requirements, anticipating this to be the majority of funding over the next three years. The company expects to continue pursuing premium rate increases and associated benefit reductions for its long-term care insurance policies, although approvals in 2025 are anticipated to be lower than previous years. Future return of capital from Enact Holdings will be based on its capital prioritization framework, and Genworth Financial expects to deploy any potential recovery from the AXA/Santander litigation towards CareScout investments, share repurchases, and opportunistic debt reduction.

Management Comments

• We continue to create shareholder value through Enact's growing market value and capital returns.
• Capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services, as well as share repurchases and opportunistic debt reduction.
• We continue to make progress on our strategic priority to maintain self-sustaining, customer-centric legacy U.S. life insurance subsidiaries.
• Our long-term care insurance multi-year in-force rate action plan continues to be our most effective tool in supporting this strategic priority.
• We plan to drive future growth through CareScout with innovative, consumer-focused aging care services and funding solutions.
• We anticipate this initial capital investment in CareScout Insurance will be the majority of the funding we allocate to this business over the next three years.
• We expect amounts in subsequent years for CareScout Insurance funding will be smaller than this initial amount.
• We believe our investments in CareScout Services and CareScout Insurance will drive sustainable future growth for Genworth and are aligned with our overarching priority to maximize long-term value for our shareholders.
• We will continue to strive to maintain a disciplined approach in our capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders and opportunistically retiring debt.
• We expect overall claims costs in our long-term care insurance business to continue to increase as our blocks age, with peak claim years over a decade away.
• We expect renewal premiums on the in-force block of our legacy long-term care insurance business to decline over time as the block runs off and as policyholders elect benefit reductions, but this decline is expected to be partially offset by future approved rate actions.
• We intend to continue to vigorously defend all ongoing legal actions.

Industry Context

The company's performance is influenced by broader macroeconomic trends, including elevated inflation impacting the cost of care in its long-term care insurance business and the U.S. Federal Reserve's interest rate policies affecting investment yields. The U.S. economy's volatility, changing economic policies, and geopolitical tensions are noted as factors that could materially impact the U.S. housing market and the Enact segment. Mortgage origination activity remains slow due to elevated mortgage rates and low housing supply, contributing to housing affordability deterioration. The private mortgage insurance industry remains highly competitive, with regulatory developments like updated PMIERs requirements influencing market dynamics. The life and annuity segments are affected by mortality trends and interest rate environments, with the company managing runoff blocks rather than actively marketing new products.

Comparison to Industry Standards

• The company's Enact segment's PMIERs sufficiency ratio of 165% or $1,961 million above requirements indicates a strong capital position relative to regulatory standards for private mortgage insurers, which is a key benchmark in the industry.
• The U.S. life insurance subsidiaries' consolidated risk-based capital ratio of approximately 304% suggests a healthy capital buffer compared to typical regulatory minimums, aligning with industry best practices for financial strength.
• The increase in the cost of care in the long-term care insurance business, due in part to elevated inflation, is a trend observed across the broader long-term care insurance industry, impacting claim payments for many providers.
• The company's strategy of pursuing premium rate increases and associated benefit reductions on in-force long-term care policies is a common industry practice among legacy long-term care insurers to improve profitability and sustainability of these blocks of business, as seen with peers like Unum Group and Northwestern Mutual who have also sought rate adjustments.

Corporate Governance

Legal Proceedings

• TVPX ARS, INC. v. GLAIC: A putative class action lawsuit alleging unlawful and excessive cost of insurance charges and breach of contract. The Eleventh Circuit affirmed the district court's denial of Genworth's motion to enforce a prior settlement, and the plaintiff refiled the complaint. Genworth intends to vigorously defend this action.
• Burkhart et al. v. Genworth Financial et al.: A putative class action lawsuit alleging intentional and constructive fraudulent transfer of dividends from GLIC to its parent, causing inadequate capital. The court granted in part Genworth's motion to dismiss, dismissing claims related to $395 million in dividends. Genworth has filed a motion for summary judgment and intends to vigorously defend.
• Trauernicht et al v. Genworth Financial: A putative class action lawsuit alleging breach of fiduciary duties under ERISA by imprudently offering and inadequately monitoring BlackRock Target Date Funds in the Savings Plan. The case was certified as a class action, and Genworth's motion for summary judgment was denied. Genworth has appealed the class certification order and intends to vigorously defend.
• M/O Arbitration Between Blue Cross Blue Shield Nebraska and GLIC: An arbitration related to BCBSNE's intent to recapture a block of long-term care insurance policies. The arbitration panel issued a final decision on May 19, 2025, resulting in Genworth making a $24 million payment and releasing $50 million in insurance reserves, leading to a $26 million pre-tax gain.
• In Re MOVEit Customer Data Security Breach Litigation: Multiple putative class action lawsuits filed against Genworth entities related to a data security breach involving the MOVEit file transfer system used by a third-party vendor. The court denied a joint motion to dismiss the complaints, and a second motion to dismiss has been filed. Genworth intends to vigorously defend these actions.
• Fox v. GLAIC: A putative class action lawsuit alleging wrongful termination of California life insurance policies by failing to provide mandated notices and grace periods. Genworth has answered the complaint and moved to strike class action allegations, and the plaintiff has moved to remand the matter to state court. Genworth intends to vigorously defend.
• Kaplan v. GLIC: A putative class action lawsuit alleging violations of the District of Columbia Consumer Protection Procedures Act due to misrepresentation and inadequate disclosure of pricing structure and likelihood of rate increases for long-term care insurance policies. Genworth has moved to dismiss the complaint and intends to vigorously defend.

Stakeholder Impact

• Shareholders: Negatively impacted by decreased net income and adjusted operating income, but positively impacted by ongoing share repurchase programs and the potential for a significant recovery from the AXA/Santander litigation.
• Policyholders: Long-term care policyholders are impacted by ongoing in-force rate actions and associated benefit reductions, but may benefit from access to the CareScout Quality Network's discounted care costs. Policyholders are also directly affected by various legal proceedings concerning policy terms and data security.
• Employees: The company's increased employee-related expenses reflect a competitive labor market. Employees are also directly impacted by the ERISA lawsuit concerning their retirement plan.
• Customers: CareScout initiatives aim to provide innovative aging care services and funding solutions, potentially benefiting consumers seeking long-term care.
• Creditors: The company's financial health, including its liquidity position and debt management strategies (e.g., opportunistic debt reduction), directly impacts creditors.

Next Steps

• Continue to add assisted living communities in large metropolitan areas and grow the home care provider network throughout the remainder of 2025.
• Invest in scaling the technology-enabled platform along with marketing and brand awareness for CareScout Services.
• Expand network access for CareScout Services to other long-term care insurance carriers with closed blocks of business, with pilot programs already underway.
• Launch the individual long-term care insurance product, CareScout Care Assurance, later in 2025, following approvals in 29 jurisdictions.
• Continue to file for additional state licenses for CareScout Care Assurance.
• Monitor macroeconomic trends, including inflation and any ancillary effects of tariff negotiations, to help mitigate potential adverse impacts to liquidity.
• Continue to vigorously defend against ongoing legal proceedings, including class action lawsuits related to cost of insurance, fraudulent transfers, ERISA fiduciary duties, data security breaches, and policy terminations.
• Evaluate the ultimate outcome of the AXA and Santander litigation, including potential appeals, to determine the final recovery amount and its deployment in line with capital allocation priorities.

Key Dates

Recommendation

The company's Q2 2025 results show a notable decline in net income and adjusted operating income, primarily driven by challenges in its legacy Long-Term Care and Life & Annuities segments. While the Enact mortgage insurance business remains strong with robust capital ratios and continues to return capital, its contribution was not enough to offset the drag from other segments. The significant potential recovery from the AXA/Santander litigation (estimated at $750 million) is a substantial positive, but it remains contingent on appeals and full payment, introducing uncertainty. Ongoing, complex litigation across multiple segments also presents a persistent overhang. Given the mixed financial performance, the strategic investments in CareScout (which are still in early stages and require capital), and the material but uncertain litigation upside, a 'Hold' recommendation is appropriate. Investors should monitor the progress of CareScout, the resolution of key litigations, and the company's ability to stabilize and improve profitability in its legacy businesses.

Keywords

Insurance, Mortgage Insurance, Long-Term Care Insurance, Life Insurance, Annuities, Financial Services, SEC Filing, 10-Q, Financial Results, Earnings, Profitability, Capital Management, Share Repurchase, Litigation, Risk Management, CareScout, PMIERs, Actuarial Assumptions, Investment Portfolio, Derivatives, Regulatory Compliance